D-0194-2025 Class III Ongoing
FDA drug recall D-0194-2025 was initiated by Akron Pharma, Inc. on December 12, 2024 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID. The recall status is ongoing. Affected quantity: 6429 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- January 22, 2025
- Initiation Date
- December 12, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6429 bottles
Product Description
Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .
Reason for Recall
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Distribution Pattern
Nationwide in the US
Code Information
Lot #: KDT0124001, Exp 08/31/2026